PBHPrestige Consumer Healthcare Inc.

Healthcare

$48.25-24% 1Y

$48.25

$44.7652 weeks$70.21

Is it safe?

Good

Strong, no red flags: a safe balance sheet and clean books.

2 good, 3 neutral, 1 without data

SurvivalSafe zone

Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.

Honest booksLow risk

Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).

Quality5 / 9

Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.

Credit gradeBBBderived · Jun 30, 2026

Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.

Drawdown risk30% volderived · Oct 9, 2026

Moderate price swings, typical volatility. Worst drawdown -54% · now 31% below its 52-week high.

Unless marked, from SEC EDGAR, as of Mar 31, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitybetter than 76% of the market

Max drawdownbetter than 70% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can PBH take a bad year?

Prestige Consumer Healthcare Inc. carries $1.93B of net debt at 6.11× EBITDA: a heavy load to carry through a bad year.

$1.93B

Net debt · as at Q1 2027 · over four years of earnings before interest, tax and depreciation, heavy

Net debt / EBITDA: 6.11×
Net debt / EBITDA · 2.37× a year ago · the load is going up
Altman Z-score: 2.24
Altman Z-score · grey zone, between 1.8 and 3
Debt / equity: 1.05×
Debt / equity